Synthesis and activity evaluation of the cyclic dipeptides arylidene N-alkoxydiketopiperazines

Bioorg Med Chem. 2016 Nov 1;24(21):5197-5205. doi: 10.1016/j.bmc.2016.08.038. Epub 2016 Aug 24.

Abstract

A series of arylidene N-alkoxydiketopiperazines was designed and stereoselectively synthesized via oxime-ether formation and intramolecular acylation. Possible cyclization and acid-catalyzed rearrangement-fragmentation mechanisms were discussed. The crystal structure of the novel diketopiperazine further confirmed the rearrangement mechanism. Most compounds exhibited antitumor activity. Several compounds were more potent against caspase-3. Specifically, compounds 6e, 6g, and 6f inhibited caspase-3 at IC50 values lying within the low micromolar range and demonstrated good selectivity. The binding modes of alkoxydiketopiperazines in the active center of caspase-3 were also discussed based on the molecular docking results.

Keywords: Antitumor activities; Arylidene N-alkoxydiketopiperazines; Caspase-3; Inhibitory activity; Molecular docking; Synthesis.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antineoplastic Agents / chemical synthesis
  • Antineoplastic Agents / chemistry
  • Antineoplastic Agents / pharmacology*
  • Caspase 3 / metabolism*
  • Cell Line, Tumor
  • Cell Proliferation / drug effects
  • Crystallography, X-Ray
  • Diketopiperazines / chemical synthesis
  • Diketopiperazines / chemistry
  • Diketopiperazines / pharmacology*
  • Dose-Response Relationship, Drug
  • Drug Screening Assays, Antitumor
  • Enzyme Inhibitors / chemical synthesis
  • Enzyme Inhibitors / chemistry
  • Enzyme Inhibitors / pharmacology*
  • Humans
  • Models, Molecular
  • Molecular Structure
  • Peptides, Cyclic / chemical synthesis
  • Peptides, Cyclic / chemistry
  • Peptides, Cyclic / pharmacology*
  • Structure-Activity Relationship

Substances

  • Antineoplastic Agents
  • Diketopiperazines
  • Enzyme Inhibitors
  • Peptides, Cyclic
  • Caspase 3